ClinicalTrials.govpublic full text
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer
head and neck cancer, esophageal cancer, otorhinolaryngologic neoplasms, ear cancer, nose cancer, laryngeal cancer, pharyngeal cancer, oncolytic virus, herpes simplex virus type 1, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 856496
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.